Clinical Trials

Are you scheduled for a stem cell transplant with cord blood? This study will assess the safety and effectiveness of certain cord blood transplants. The study will help researchers learn the best methods for collecting, storing, and using cord blood in transplants. To participate in this study, you must have a disorder that compromises your body’s ability to make blood cells. This study is located in Bethesda, Maryland.

Are you an adult who has granulomatosis with polyangiitis (GPA)? This study is testing whether prednisone affects flares for people who have GPA, a type of vasculitis, that is in remission. To participate in this study, you must be at least 18 years old and have GPA that was active within the last year but is currently in remission.

Therapeutics for Inpatients With COVID-19 (TICO) This study will investigate the safety and effectiveness of different medicines, such as remdesivir, in treating people who have been hospitalized for COVID-19. To participate in this study, you must be at least 18 years old, be hospitalized for COVID-19 treatment, and have had symptoms for less than 12 days. This study is located in Atlanta, Georgia; Durham and Winston-Salem, North Carolina; Nashville, Tennessee; and Dallas, Texas.

Are you pregnant and also diagnosed with high blood pressure? This study aims to study the benefits and risks of medicine to treat pregnant women who have mild high blood pressure (

Do you or your child have severe asthma that is not easily controlled by inhaled corticosteroids? This study evaluates the use of five different asthma medicines to treat adults and adolescents with severe asthma. To participate in this study, you or your child must be 12 years old or older. This study takes place in multiple locations across the United States.

Are you or your child between 12 and 35 years old, currently using an inhaler to treat asthma, and interested in supporting research into telehealth to control and improve asthma symptoms? This study is evaluating the use of video telehealthcare to help adolescents and young adults with asthma take their medication correctly and on time. This study takes place in multiple locations across the United States.

Are you an adult who has been diagnosed with idiopathic pulmonary fibrosis (IPF)? This study will examine whether adding N-acetylcysteine (NAC) to standard treatment improves key indicators of IPF, including symptoms, in people with the TOLLIP rs3750920 TT genotype who are living with the disease. You must be age 40 or older to participate in this study. This study takes place in multiple locations.

Have you been diagnosed with LAM? This study is trying to understand the genes and proteins that are responsible for causing lung damage in patients with LAM. To participate in this study, you must be between 16 and 99 years old and diagnosed with LAM. This study is located in Bethesda, Maryland.

Are you an adult female who has been diagnosed with LAM? This study is examining which delivery method of albuterol—inhaled or nebulizer—is better at improving lung function in adult women who have LAM. This study is located in Bethesda, Maryland.

Do you or does your child have a lipid disorder and want to improve future diagnosis and treatment? This study is exploring how different diagnostic tests can help us understand how lipid disorders, including high blood cholesterol, affect the body. Information from this study may help improve the way lipid disorders are diagnosed or treated in the future. To participate, you or your child must be at least 2 years old. The study is being conducted in Bethesda, Maryland.